Index of reports
> Life Threatening Events (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Namenda (Memantine) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Namenda side effects in 78 year old male
Reported by a individual with unspecified qualification from United States on 2012-02-02
Patient: 78 year old male, weighing 36.3 kg (79.8 pounds)
Reactions: Affective Disorder, Balance Disorder, Aphasia, Amnesia, Loss of Consciousness, Convulsion
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Namenda
Possible Namenda side effects in 82 year old male
Reported by a physician from United States on 2011-12-01
Patient: 82 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Refusal of Treatment by Patient, Alanine Aminotransferase Increased, Blood Bilirubin Unconjugated Increased, Pyrexia, Cholecystitis Chronic, Lactic Acidosis, Fall, Cholelithiasis, Aspartate Aminotransferase Increased, Dizziness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Aricept
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2009-12-15
Placebo
Indication: Dementia Alzheimer's Type
Start date: 2011-08-05
Namenda
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2010-01-08
Other drugs received by patient: Aspirin; Ascorbic Acid; Multi-Vitamins; Cephalexin; Iron
Possible Namenda side effects in female
Reported by a physician from United States on 2011-11-04
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Chest Discomfort, Bundle Branch Block Left, Concomitant Disease Progression, Loss of Consciousness, Chest Pain, Dizziness, Acute Myocardial Infarction, Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Namenda
Dosage: 10 mg, bid
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2007-02-13
End date: 2007-05-13
Exelon
Dosage: 3 mg, bid
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2007-02-13
End date: 2007-05-13
Other drugs received by patient: Warfarin Sodium; Toprol-XL; Lisinopril
|